Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
J&J will defend its proposed 340B changes as US threatens penalties
7 months ago
FDA+
FTC to sue major PBMs over insulin rebates, claiming they inflated patient cost
7 months ago
Pharma
Cigna sues FTC, calling for withdrawal of 'biased, erroneous' PBM report
7 months ago
Pharma
Health Tech
SEC probe of Illumina’s Grail deal targets sales forecasts, sources say
7 months ago
Deals
After a huge IPO and acquisition, Zymergen caps off bankruptcy with $30M SEC penalty
7 months ago
CVS says it won't correct congressional testimony
8 months ago
Congress spars over whether the Biosecure Act is an overdue crackdown or a rushed witch hunt
8 months ago
China
FDA+
House passes Biosecure Act, sending Chinese biotech ban to Senate
8 months ago
China
Manufacturing
Federal judge rejects pharma industry’s request to halt Maryland’s 340B law
8 months ago
Pharma
J&J increases talc settlement by $1.1B after negotiating with plaintiffs, lawyers say
8 months ago
Pharma
Ocaliva will continue to be available in the EU following European court's decision
8 months ago
Pharma
Court orders J&J to pay $1B following buyout of surgical robotics company
8 months ago
Pharma
Biosecure vote slated for September
8 months ago
China
FDA+
Pennsylvania judge sides with drugmakers on first steps for growing GLP-1 lawsuits
8 months ago
Pharma
FDA+
FDA hints at what Chevron's elimination means in new SCOTUS filing
8 months ago
FDA+
Delaware high court to review expert testimony in Zantac suits, in win for drugmakers
8 months ago
Pharma
Regeneron sues Sandoz to halt biosimilar to its blockbuster eye drug
8 months ago
Pharma
Ipsen files another Onivyde lawsuit two weeks after receiving new patent
8 months ago
Pharma
J&J grants 'short extension' for certification of talc settlement vote
8 months ago
Pharma
Liquidia sues FDA over exclusivity decision to delay Yutrepia's full approval
8 months ago
FDA+
Lawsuit alleges Biogen schemed with PBMs to preserve Tecfidera market
8 months ago
Pfizer brings Indian generics maker to court over Xeljanz patent
8 months ago
Pharma
Medicare negotiations have concluded. What's next for court cases against the IRA?
8 months ago
Pharma
Biden administration says IRA negotiations will result in $6B in 2026 Medicare savings
8 months ago
FDA+
First page
Previous page
5
6
7
8
9
10
11
Next page
Last page